Concepedia

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

Stephen Gough, Bruce W. Bode, Vincent Woo, Helena W. Rodbard, Sultan Linjawi, Pernille Poulsen, L.H. Damgaard, John B. Buse

The Lancet Diabetes & Endocrinology · 2014 · 362 citations · 11 references

DOI

Concepts

References

11

A Simple Sequentially Rejective Multiple Test Procedure

Sture Holm · Scandinavian Journal of Statistics · 1979 · 21.8K citations

, , +8

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

S. E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetologia · 2012 · 3.9K citations · Full text

, , +13

DECLARATION OF HELSINKI.

Bryan Gandevia, Ann Tovell · PubMed · 1964 · 2.1K citations

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Anne Flint, Anne Raben, Arne Astrup et al. · Journal of Clinical Investigation · 1998 · 1.4K citations · Full text

, , +17

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

Michael A. Nauck, N. Kleine, C. �rskov et al. · Diabetologia · 1993 · 1.1K citations · Full text

, , +15